Wuxi Biologics (Cayman) (HK:2269) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
WuXi Biologics (Cayman) Inc. has announced a significant board change, as Dr. Yibing Wu resigns from his position as non-executive director and member of the strategy committee to focus on personal commitments. Replacing him is Ms. Jingwen Miao, a seasoned investment director from Temasek International, who brings extensive experience in the life sciences sector to the board. This change is expected to bring a fresh perspective to the company’s strategic direction.
For further insights into HK:2269 stock, check out TipRanks’ Stock Analysis page.
